G04CA04 · Genito-urinary system and sex hormones
Silodosin Recordati
Indications
Treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) in adult men.
Composition
- Active substance
- silodosin
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Silodosin Recordati
- Active substance
- silodosin
- ATC code
- G04CA04
- Therapeutic area
- Prostatic Hyperplasia
- Marketing authorisation holder
- Recordati Ireland Ltd
- Status
- Authorised
- EU authorisation
- 7 Jan 2019